📚 The Significance of Telomeres | 端粒的重要性
Telomeres are repetitive nucleotide sequences at the ends of linear chromosomes that protect genetic information from degradation and fusion. Their significance extends far beyond simple caps – they are intimately involved in cellular ageing, the limitation of replicative lifespan, and the development of cancer. Understanding telomere biology is a central theme in Cambridge A-Level Biology, linking DNA replication, the cell cycle, gene expression, and human disease.
端粒是线性染色体末端的重复核苷酸序列，可保护遗传信息免遭降解和融合。它们的意义远不止简单的“帽子”——端粒与细胞衰老、复制寿命的受限以及癌症的发生都有着密切关联。理解端粒生物学是剑桥 A-Level 生物学的核心主题之一，它将 DNA 复制、细胞周期、基因表达和人类疾病紧密联系在一起。
1. Structure of Telomeres | 端粒的结构
In humans and other vertebrates, telomeric DNA consists of tandem repeats of the hexanucleotide sequence 5′-TTAGGG-3′. This G-rich strand extends beyond its complementary C-rich strand, forming a single-stranded 3′ overhang of about 100–300 nucleotides. The overhang folds back and invades the double-stranded telomeric region, creating a T-loop (telomere loop) that resembles a knot. The T-loop is stabilised by shelterin, a six-protein complex that specifically binds telomeric repeats and caps the chromosome end.
在人类和其他脊椎动物中，端粒 DNA 由六核苷酸序列 5′-TTAGGG-3′ 的串联重复组成。这条富含 G 的链会超出其互补的 C 链，形成一个长约 100–300 个核苷酸的单链 3′ 突出端。该突出端向后折叠并侵入双链端粒区域，形成一个类似结的 T 环（端粒环）。T 环由 shelterin 庇护蛋白复合体稳定，该复合体由六种蛋白组成，可特异性结合端粒重复序列并给染色体末端“戴帽”。
The shelterin complex includes TRF1, TRF2, POT1, TPP1, TIN2 and RAP1. Together, they prevent the cell’s DNA damage response machinery from recognising the natural chromosome end as a double-strand break. Without this protective cap, chromosome ends would be vulnerable to nucleolytic degradation, inappropriate recombination, and end-to-end fusion.
Shelterin 复合体包含 TRF1、TRF2、POT1、TPP1、TIN2 和 RAP1。它们共同阻止细胞的 DNA 损伤应答机器将天然染色体末端识别为双链断裂。如果没有这顶保护帽，染色体末端就很容易被核酸酶降解、发生不当重组和末端融合。
2. The End-Replication Problem | 末端复制问题
During DNA replication, the lagging strand is synthesised discontinuously as Okazaki fragments, each requiring an RNA primer to be laid down by primase. When the last RNA primer at the 3′ end of the parental lagging strand is removed, a short gap remains that cannot be filled by DNA polymerase because no 3′-OH is available for extension. Consequently, with every round of semi-conservative replication, the 5′ end of the newly synthesised lagging strand becomes shorter by the length of the removed primer.
在 DNA 复制过程中，后随链以冈崎片段的形式不连续合成，每个片段都需要由引物酶放置一段 RNA 引物。当亲本后随链 3′ 末端最后一个 RNA 引物被移除后，会留下一个短缺口，而 DNA 聚合酶无法填补该缺口，因为无法获得可延伸的 3′-OH。因此，每一轮半保留复制都会使新合成的后随链的 5′ 末端缩短一个引物的长度。
This progressive loss of terminal DNA, known as the end-replication problem, means that linear chromosomes become slightly shorter with each cell division. In the absence of a compensation mechanism, genes located near the ends of chromosomes would eventually be lost, leading to genomic instability and cell death. Telomeres act as sacrificial buffers – they do not code for proteins, so their shortening does not immediately compromise essential genetic information.
这种末端 DNA 的逐步丢失，被称为末端复制问题，意味着线性染色体在每次细胞分裂时都会略微缩短。如果没有补偿机制，位于染色体末端的基因最终会丢失，导致基因组不稳定和细胞死亡。端粒充当了牺牲缓冲序列——它们不编码蛋白质，因此其缩短不会立即危及重要的遗传信息。
3. Telomeres as a Mitotic Clock | 端粒作为有丝分裂时钟
The concept of a ‘mitotic clock’ emerged from the work of Leonard Hayflick, who demonstrated that normal human fibroblasts in culture divide a finite number of times (the Hayflick limit) before entering irreversible growth arrest called replicative senescence. It was later shown that telomere length correlates with the number of divisions a cell has undergone. Once telomeres become critically short, the uncapped chromosome ends trigger a persistent DNA damage response, activating tumour suppressor pathways such as p53 and pRb.
“有丝分裂时钟”的概念源自 Leonard Hayflick 的研究，他证明培养的正常人成纤维细胞在分裂有限次数（Hayflick 极限）后便会进入不可逆的生长停滞，即复制性衰老。后来发现端粒长度与细胞经历的分裂次数相关。一旦端粒变得极短，未加帽的染色体末端就会触发持久的 DNA 损伤应答，激活 p53 和 pRb 等抑癌通路。
This response leads to senescence, a state in which cells remain metabolically active but can no longer divide. Senescence is thought to act as a tumour-suppressive barrier: it prevents potentially cancerous cells with very short telomeres from accumulating further mutations through continued proliferation. Thus, telomere shortening functions as a built-in mechanism that limits the replicative capacity of somatic cells.
该应答会导致衰老（senescence），在此状态下细胞保持代谢活性但不再分裂。衰老被认为是一种抑癌屏障：它阻止端粒极短的可能癌变细胞通过继续增殖积累更多突变。因此，端粒缩短是一种内置机制，限制了体细胞的复制能力。
4. Telomerase – the Cellular Reverse Transcriptase | 端粒酶——细胞内的逆转录酶
Certain cell types must divide many times to maintain tissue homeostasis or support reproduction. These cells – including germline cells, stem cells, and activated lymphocytes – express telomerase, a specialised ribonucleoprotein enzyme that counteracts telomere shortening. Telomerase is a reverse transcriptase: it synthesises DNA using an RNA template that is an integral part of the enzyme. The RNA component, called TERC (telomerase RNA component), contains a short sequence complementary to the telomeric repeat (3′-AAUCCC-5′ in humans).
某些细胞类型需要多次分裂以维持组织稳态或支持生殖。这些细胞——包括生殖系细胞、干细胞和活化淋巴细胞——表达端粒酶（telomerase），这是一种特化的核糖核蛋白酶，可抵消端粒缩短。端粒酶是一种逆转录酶：它利用酶本身携带的一段 RNA 作为模板来合成 DNA。RNA 组分称为 TERC（端粒酶 RNA 组分），包含一段与端粒重复序列互补的短序列（人类的 3′-AAUCCC-5’）。
The catalytic protein subunit TERT (telomerase reverse transcriptase) extends the 3′ overhang of the parental strand by adding TTAGGG repeats. After extension, primase, DNA polymerase, and ligase can fill in the complementary C-rich strand, effectively lengthening the telomere. Without telomerase activity, the overhang would gradually erode, eventually exposing the coding regions of the chromosome.
催化性蛋白亚基 TERT（端粒酶逆转录酶）通过在亲本链的 3′ 突出端上添加 TTAGGG 重复序列来进行延伸。延伸后，引物酶、DNA 聚合酶和连接酶即可填补互补的 C 富集链，从而有效延长端粒。若没有端粒酶活性，突出端会逐渐磨损，最终暴露染色体上的编码区域。
5. Telomerase Activity in Normal and Cancer Cells | 正常细胞与癌细胞中的端粒酶活性
In most human somatic cells, the TERT gene is transcriptionally repressed, and telomerase activity is undetectable or extremely low. As a result, these cells undergo progressive telomere shortening with age and division. In contrast, approximately 85–90% of human cancers show significant telomerase activation, which allows cancer cells to divide indefinitely and achieve replicative immortality – one of the classical hallmarks of cancer described by Hanahan and Weinberg.
在大多数人体细胞中，TERT 基因被转录抑制，端粒酶活性检测不到或极低。因此，随着衰老和分裂，这些细胞的端粒逐渐缩短。相比之下，约 85–90% 的人类癌症表现出显著的端粒酶激活，这使得癌细胞能够无限分裂并获得复制永生——这是 Hanahan 和 Weinberg 描述的经典癌症特征之一。
The remaining cancers maintain telomeres through an alternative lengthening of telomeres (ALT) pathway, which relies on homologous recombination between telomeric repeats. Both mechanisms ensure that cancer cells can avoid the senescence and crisis barriers that normally limit the lifespan of precancerous cells. Precisely because of its selective expression in cancer, telomerase has become a promising target for anti-cancer therapies.
其余癌症则通过端粒的替代延长（ALT）途径来维持端粒长度，该途径依赖于端粒重复序列间的同源重组。两种机制都确保癌细胞能绕过正常限制癌前细胞寿命的衰老障碍和危机阶段。正是因为端粒酶在癌症中的选择性表达，它已成为颇具潜力的抗癌治疗靶点。
6. Telomere Shortening and Human Ageing | 端粒缩短与人体衰老
Epidemiological studies have linked shorter leukocyte telomere length with age-related diseases such as cardiovascular disease, type 2 diabetes, and pulmonary fibrosis. Telomere attrition is influenced by genetic factors, chronic inflammation, oxidative stress, and lifestyle factors including smoking, poor diet, and lack of exercise. Thus, telomere length is increasingly viewed as a biomarker of biological age rather than simply chronological age.
流行病学研究已将较短的白细胞端粒长度与心血管疾病、2 型糖尿病和肺纤维化等与年龄相关的疾病联系起来。端粒损耗受遗传因素、慢性炎症、氧化应激以及吸烟、不良饮食和缺乏运动等生活方式因素的影响。因此，端粒长度越来越被视为生物年龄而非简单时序年龄的生物标志物。
Accelerated telomere shortening is a hallmark of several premature ageing syndromes, such as dyskeratosis congenita and idiopathic pulmonary fibrosis. Mutations in genes encoding components of telomerase (TERT, TERC) or shelterin can lead to critically short telomeres, which in turn cause bone marrow failure, skin abnormalities, and increased cancer risk. These observations provide strong evidence that adequate telomere maintenance is essential for tissue renewal and long-term health.
加速的端粒缩短是多种早衰综合征的标志，例如先天性角化不良和特发性肺纤维化。编码端粒酶组分（TERT、TERC）或 shelterin 蛋白的基因发生突变可导致端粒严重缩短，进而造成骨髓衰竭、皮肤异常和癌症风险升高。这些观察有力证明，充足的端粒维持对组织更新和长期健康至关重要。
7. Protective Functions of Telomeres | 端粒的保护功能
Beyond serving as a buffer against DNA loss, telomeres have a crucial architectural role. The T-loop conformation prevents the exposed chromosome end from being mistaken for a double-strand break by the non-homologous end joining (NHEJ) machinery. If a chromosome end were recognised as broken, NHEJ would fuse it to another chromosome end, forming dicentric chromosomes that lead to breakage-fusion-bridge cycles, massive genomic instability, and cell death.
除了充当抵御 DNA 丢失的缓冲序列外，端粒还承担着至关重要的结构角色。T 环构象可防止暴露的染色体末端被非同源末端连接（NHEJ）机器误认为双链断裂。如果染色体末端被识别为断裂，NHEJ 会将其与另一条染色体末端融合，形成双着丝粒染色体，进而引发断裂-融合-桥循环、大规模基因组不稳定和细胞死亡。
Telomeres also suppress DNA damage signalling. Shelterin components such as TRF2 and POT1 prevent the activation of ATM and ATR kinases, which are normally triggered by DNA damage. By binding to the overhang, POT1 blocks the binding of RPA, the single-stranded DNA sensor that initiates the ATR pathway. This local inhibition ensures that the normal chromosome end is immunologically ‘silent’.
端粒还能抑制 DNA 损伤信号。Shelterin 组分如 TRF2 和 POT1 可阻止 ATM 和 ATR 激酶的激活，这些激酶通常由 DNA 损伤所触发。POT1 通过结合突出端，竞争性地阻止单链 DNA 传感器 RPA 的结合，而 RPA 会启动 ATR 通路。这种局部抑制确保了正常染色体末端在免疫学上保持“沉默”。
8. Telomere Length Regulation and Epigenetics | 端粒长度的调控与表观遗传学
Telomere length is not solely determined by the presence or absence of telomerase. The telomeric and subtelomeric chromatin is enriched in heterochromatic marks, including histone H3 trimethylation at lysine 9 (H3K9me3) and lysine 20 (H3K20me3). Loss of these repressive marks leads to abnormally elongated telomeres even in the presence of normal telomerase levels, indicating that a compact chromatin structure inhibits excessive elongation.
端粒长度并非仅由端粒酶的有无决定。端粒区和亚端粒区染色质富含异染色质标记，包括组蛋白 H3 第 9 位赖氨酸的三甲基化 (H3K9me3) 和第 20 位赖氨酸的三甲基化 (H3K20me3)。即使端粒酶水平正常，这些抑制性标记的缺失也会导致端粒异常延长，这表明紧密的染色质结构能抑制过度延伸。
Additionally, non-coding RNA transcribed from telomeric repeats (TERRA) helps regulate telomere length and recombination. TERRA molecules associate with telomeres and can modulate telomerase access. Environmental factors such as chronic stress and socioeconomic deprivation have been correlated with accelerated telomere shortening, potentially via cortisol-induced oxidative stress and altered telomerase activity.
此外，由端粒重复序列转录产生的非编码 RNA（TERRA）有助于调控端粒长度和重组。TERRA 分子与端粒结合，可调节端粒酶的可及性。慢性压力和社会经济匮乏等环境因素与端粒加速缩短相关，其可能机制是通过皮质醇诱导的氧化应激及端粒酶活性的改变。
9. Telomerase Knockout and Mouse Models | 端粒酶敲除与小鼠模型
Genetically engineered mouse models have been instrumental in uncovering the roles of telomerase in vivo. Mice with Tert or Terc knockout show progressive telomere shortening over several generations. Initially, these mice are phenotypically normal, but after three to four generations they develop severe defects in highly proliferative tissues, including bone marrow failure, intestinal atrophy, impaired wound healing, and infertility. These phenotypes demonstrate that telomerase is essential for the long-term regenerative capacity of tissues.
基因工程小鼠模型在揭示端粒酶的体内功能方面发挥了重要作用。Tert 或 Terc 基因敲除的小鼠在连续数代中表现出进行性端粒缩短。起初，这些小鼠表型正常，但经过三至四代后，它们会在高度增殖的组织中出现严重缺陷，包括骨髓衰竭、肠萎缩、伤口愈合受损和不育。这些表型表明端粒酶对组织长期再生能力至关重要。
Interestingly, when such telomerase-deficient mice are engineered to also lack p53, the apoptosis and senescence responses are abrogated, allowing some cell survival, but the risk of developing tumours increases dramatically. This elegantly illustrates the role of p53 as a sensor that connects telomere dysfunction to tumour suppression.
有趣的是，当这些端粒酶缺陷小鼠同时被改造为缺乏 p53 时，凋亡和衰老应答被消除，部分细胞得以存活，但发生肿瘤的风险急剧增加。这精妙地说明了 p53 作为传感器将端粒功能障碍与肿瘤抑制联系起来的角色。
10. Therapeutic Potential and Clinical Implications | 治疗潜力与临床意义
The telomerase field has sparked intense interest in drug development. Telomerase inhibitors, such as imetelstat (a lipid-conjugated oligonucleotide that binds to TERC), have been tested in clinical trials for myelofibrosis and other haematological malignancies. The rationale is that inhibiting telomerase in cancer cells will lead to their eventual senescence or apoptosis after progressive telomere shortening, sparing normal somatic cells that do not rely on telomerase.
端粒酶领域已引发了对药物开发的浓厚兴趣。端粒酶抑制剂，如 imetelstat（一种结合 TERC 的脂质偶联寡核苷酸），已在骨髓纤维化和其他血液系统恶性肿瘤的临床试验中进行测试。其理论依据是，抑制癌细胞中的端粒酶将导致端粒逐步缩短后最终进入衰老或凋亡，而不依赖于端粒酶的正常体细胞则不受影响。
Conversely, transient activation of telomerase has been explored as a potential therapy for age-related degenerative diseases. However, the risk of facilitating tumour growth means that any therapeutic manipulation must be tightly controlled and targeted. Furthermore, measuring telomere length in clinical settings has been proposed as a prognostic marker for disease progression and a predictor of response to certain treatments.
另一方面，短暂激活端粒酶也被探索作为治疗年龄相关退行性疾病的潜在手段。然而，促进肿瘤生长的风险意味着任何治疗性操作都必须受到严格控制并实现靶向。此外，在临床中测量端粒长度已被提议作为疾病进展的预后标志物和对某些治疗反应的预测因子。
11. Telomeres in the Context of the Cell Cycle and DNA Damage Checkpoints | 端粒在细胞周期和 DNA 损伤检查点中的背景
Critically short telomeres are detected at the G1/S and G2/M checkpoints of the cell cycle. The DNA damage sensor kinase ATM is recruited, leading to phosphorylation of CHK2 and stabilisation of p53. Accumulated p53 transactivates the CDK inhibitor p21, which blocks cyclin-CDK activity and arrests the cell in G1. If damage is detected later in the cycle, the ATR-CHK1 pathway may halt progression at the G2/M boundary.
严重缩短的端粒会在细胞周期的 G1/S 和 G2/M 检查点被检测到。DNA 损伤传感器激酶 ATM 被招募，导致 CHK2 磷酸化和 p53 稳定化。积累的 p53 反式激活 CDK 抑制剂 p21，阻断周期蛋白-CDK 活性并将细胞阻滞在 G1 期。如果在后期检测到损伤，ATR-CHK1 通路可能会在 G2/M 交界处阻止细胞周期进程。
This integration of telomere status with the cell-cycle machinery ensures that cells with compromised genome integrity do not pass on damaged chromosomes to daughter cells. From an evolutionary perspective, telomere-driven senescence can be seen as a programmed fail-safe that prevents the propagation of potentially oncogenic mutations.
端粒状态与细胞周期机器的这种整合，确保了基因组完整性受损的细胞不会将损伤的染色体传递给子细胞。从进化的角度来看，端粒驱动的衰老可被视为一种程序化的安全机制，阻止潜在致癌突变的传播。
12. Summary and A-Level Key Points | 总结与 A-Level 核心要点
In summary, telomeres are indispensable for chromosome stability. They solve the end-replication problem through their repetitive, non-coding sequences and sophisticated loop structures. Progressive telomere shortening defines a ‘mitotic clock’ that limits the replicative lifespan of somatic cells and provides a natural barrier to tumour formation. Telomerase extends telomeres in germline cells, stem cells, and the majority of cancers, granting unlimited proliferative potential. The interplay between telomere length, shelterin protection, and checkpoint activation elegantly links DNA replication to cell ageing and cancer biology.
总之，端粒对染色体稳定性是不可或缺的。它们通过重复的非编码序列和精巧的环状结构解决了末端复制问题。进行性的端粒缩短定义了一个“有丝分裂时钟”，限制了体细胞的复制寿命，并提供了天然的肿瘤形成屏障。端粒酶能延长生殖系细胞、干细胞和绝大多数癌症中的端粒，赋予其无限的增殖潜力。端粒长度、shelterin 保护和检查点激活之间的相互作用，将 DNA 复制与细胞衰老以及癌症生物学精巧地联系在了一起。
For Cambridge A-Level Biology, students should be able to explain the end-replication problem, describe the structure and functions of telomeres and telomerase, link telomere shortening to the Hayflick limit and senescence, and relate telomerase reactivation to the development of cancer. Understanding these concepts provides crucial insight into the molecular mechanisms underlying ageing and tumourigenesis.
对于剑桥 A-Level 生物学，学生应能解释末端复制问题，描述端粒和端粒酶的结构与功能，将端粒缩短与 Hayflick 极限和衰老联系起来，并将端粒酶的重新激活与癌症的发生联系起来。理解这些概念能为深刻认识衰老和肿瘤发生的分子机制提供关键视角。
Published by TutorHao | Biology Revision Series | aleveler.com
更多咨询请联系16621398022（同微信）
屏轩国际教育cambridge primary/secondary checkpoint, cat4, ukiset,ukcat,igcse,alevel,PAT,STEP,MAT, ibdp,ap,ssat,sat,sat2课程辅导，国外大学本科硕士研究生博士课程论文辅导